<p>Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway</p>Pijian Yang, Ning Xia|Diabetes Metabolic Syndrome and Obesity|2019Cited by 33